Associated Papers
Real-world experience of afatinib as first-line therapy for advanced EGFR mutation-positive non-small cell lung cancer in Korea.
Lee SY et al.
Translational Lung Cancer Research, 2021
Clinical significance of EGFR mutation types in lung adenocarcinoma: A multi-centre Korean study.
Yoon HY et al.
Plos One, 2020
32053675 (PubMed )
Supplement: pone.0228925.s006.xlsx › Sheet1
Detection of EGFR mutation status in lung adenocarcinoma specimens with different proportions of tumor cells using two methods of differential sensitivity.
Han HS et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, 2012
Select a paper to view details